Publications (42) Manuel José Morales González publications

filter_list

2024

  1. Changes in AmotL2 Expression in Cells of the Human Enteral Nervous System in Oxaliplatin-Induced Enteric Neuropathy

    Biomedicines, Vol. 12, Núm. 9

  2. Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention

    BMC Neuroscience, Vol. 25, Núm. 1

2022

  1. AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches

    Journal of Histochemistry and Cytochemistry, Vol. 70, Núm. 1, pp. 9-16

  2. FKBP51, AmotL2 and IQGAP1 Involvement in Cilastatin Prevention of Cisplatin-Induced Tubular Nephrotoxicity in Rats

    Cells, Vol. 11, Núm. 9, pp. 1585

  3. Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment

    Biomedicines, Vol. 10, Núm. 6, pp. 1271

2021

  1. Treatment of established chemotherapy-induced peripheral neuropathy: Basic science and animal models

    Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy: A MASCC Book (Springer), pp. 137-153

2019

  1. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview

    Supportive Care in Cancer, Vol. 27, Núm. 10, pp. 3729-3737

  2. IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment

    Journal of Histochemistry and Cytochemistry, Vol. 67, Núm. 7, pp. 481-494

  3. Whole-exome sequencing identifies somatic mutations associated with mortality in metastatic clear cell kidney carcinoma

    Frontiers in Genetics, Vol. 10, Núm. MAY

2017

  1. Alterations in IQGAP1 expression and localization in colorectal carcinoma and liver metastases following oxaliplatin-based chemotherapy

    Oncology Letters, Vol. 14, Núm. 3, pp. 2621-2628

  2. Commitment of scaffold proteins in the onco-biology of human colorectal cancer and liver metastases after oxaliplatin-based chemotherapy

    International Journal of Molecular Sciences, Vol. 18, Núm. 4

  3. IQGAP1 in podosomes/invadosomes is involved in the progression of glioblastoma multiforme depending on the tumor status

    International Journal of Molecular Sciences, Vol. 18, Núm. 1

  4. Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry

    PLoS ONE, Vol. 12, Núm. 5

  5. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group

    Cancer, Vol. 123, Núm. 19, pp. 3709-3716

  6. The Na, K-ATPase β-subunit isoforms expression in glioblastoma multiforme: Moonlighting roles

    International Journal of Molecular Sciences, Vol. 18, Núm. 11

2016

  1. Expression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapy

    Oncology Letters, Vol. 12, Núm. 2, pp. 1315-1322

  2. Na,K-ATPase isozymes in colorectal cancer and liver metastases

    Frontiers in Physiology, Vol. 7, Núm. JAN

2014

  1. Differential transcriptome profile of peripheral white cells to identify biomarkers involved in oxaliplatin induced neuropathy

    Journal of Personalized Medicine, Vol. 4, Núm. 2, pp. 282-296

2013

  1. Use of panitumumab in the treatment of acinar cell carcinoma of the pancreas: A case report

    Oncology Letters, Vol. 5, Núm. 3, pp. 969-971

2012

  1. Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?

    Clinical and Translational Oncology, Vol. 14, Núm. 5, pp. 386-390